The BATTLE trial was designed to compare paclitaxel eluting stents ( Zilver PTX ) and a last generation bare self-expandable nitinol stents ( Misago RX , Terumo Corp. , Tokyo , Japan ) in the treatment of intermediate length femoropopliteal lesions ( 14 cm ) .